Both Semaglutide and Semaglutide belong to a class of therapies called GLP-One receptor agonists . These innovative substances work by imitating the body's natural chemical , GLP-1 , to assist reduce sugar in the blood and stimulate weight reduction . This shared mechanism of effect demonstrates why such therapies are commonly evaluated together an